Physician profile
Antonius Su
NPI 1891783775
$10,708.40
in general payments reported to CMS, 2019-2025
44 companies · $921 in 2025
The $921 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,323 · 2020: $444 · 2021: $970 · 2022: $999 · 2023: $2,031 · 2024: $2,020 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,236 · Travel and Lodging: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.43 |
| Travel and Lodging | $1,735.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $2,378.14 | 2023-2024 | |
| Kci USA, INC. | $1,319.63 | 2019-2020 | |
| Goode Surgical INC | $1,196.42 | 2019 | |
| Horizon Therapeutics Plc | $929.17 | 2019-2023 | Krystexxa |
| Stryker Corporation | $521.70 | 2019-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Anchorage |
| Vaporox, INC. | $458.38 | 2022 | |
| Forthright Medical - Az, LLC | $448.27 | 2024-2025 | Vilex Guidewire |
| Musculoskeletal Transplant Foundation INC. | $410.31 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $366.80 | 2019-2024 | Jublia |
| Smith+Nephew, INC. | $333.35 | 2020-2025 | Collagenase Santyl, Invisiknot, Grafix Pl |
| Amgen INC. | $313.25 | 2024-2025 | Krystexxa |
| Nevro Corp. | $271.85 | 2021-2023 | Senza |
| Bioventus LLC | $197.12 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $154.66 | 2019-2025 | Nushield, Puraply Wound Matrix |
| Vilex LLC | $141.94 | 2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $112.94 | 2019 | |
| Djo, LLC | $94.88 | 2021-2025 | Cmf |
| Biocomposites INC | $90.49 | 2023 | Stimulan |
| Paratek Pharmaceuticals, INC. | $88.71 | 2021-2025 | Nuzyra |
| Impactortho, INC. | $80.47 | 2022 | |
| Depuy Synthes Sales INC. | $75.60 | 2019-2025 | Motoband |
| Aap Implants INC | $65.96 | 2021-2022 | |
| Orthofix Medical, INC. | $62.27 | 2019-2025 | Miscellaneous |
| Tactile Systems Technology INC | $60.53 | 2019-2025 | Nimbl, Flexitouch Plus |
| Fusion Orthopedics USA, LLC | $53.86 | 2025 | |
| Averitas Pharma INC. | $51.31 | 2024 | Qutenza |
| Advanced Oxygen Therapy INC. | $39.90 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Medtronic, INC. | $38.85 | 2024-2025 | Intellis Adaptivestim |
| Rikco International, LLC | $36.83 | 2019-2021 | |
| Abbott Laboratories | $35.37 | 2024 | Proclaim |
| Zimmer Biomet Holdings, INC. | $34.05 | 2023 | Tapestry |
| Mimedx Group, INC. | $33.72 | 2025 | |
| Ossio INC | $28.83 | 2023 | |
| Abbvie INC. | $23.04 | 2025 | |
| Kerecis Limited | $20.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Osteocentric Technologies, INC. | $19.17 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Hartmann USA, INC. | $18.28 | 2025 | Zetuvit Plus 10x10 P10 |
| Nabriva Therapeutics, Plc | $17.57 | 2022 | |
| Alfasigma USA, INC. | $16.30 | 2021 | |
| Treace Medical Concepts, INC. | $15.29 | 2022 | |
| Innovation Technologies INC | $14.02 | 2024 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $13.75 | 2023 | Seglentis |
| Melinta Therapeutics, LLC | $13.14 | 2019 | |
| Integra Lifesciences Corporation | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonius Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.